AbbVie Inc. (ABBV) Ownership
ABBV ownership summary
as of October 18, 2026- Institutions
- 77.3% of shares outstanding
- Insiders
- 0.11% of shares outstanding
- Shares outstanding
- 1.77B
- Float
- 1.76B shares available to trade
- Short interest
- 1.02% 16.3M shares short
- Days to cover
- 3.93 short interest down 16.6% vs prior month
- Institutions 77.33%
- Insiders 0.11%
- Other investors 22.56%
ABBV top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.46% | 149.5M | $42.67B | −1.2M (−0.8%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.53% | 115.4M | $32.94B | +515,774 (+0.4%) | June 30, 2026 |
| 3 | State Street Corp | 4.67% | 82.6M | $23.57B | +1.4M (+1.7%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 2.74% | 48.5M | $13.84B | −1.0M (−2.1%) | June 30, 2026 |
| 5 | JPMorgan Chase & Co | 2.71% | 47.9M | $13.66B | −8.9M (−15.6%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 2.66% | 47.0M | $13.41B | +260,852 (+0.6%) | June 30, 2026 |
| 7 | Morgan Stanley - Brokerage Accounts | 2.20% | 38.9M | $11.10B | +884,227 (+2.3%) | June 30, 2026 |
| 8 | Capital Research Global Investors | 1.70% | 30.1M | $8.59B | −1.2M (−3.7%) | June 30, 2026 |
| 9 | NORGES BANK | 1.45% | 25.6M | $7.29B | −114,223 (−0.4%) | June 30, 2026 |
| 10 | Bank of America Corp | 1.20% | 21.2M | $6.06B | −2.7M (−11.3%) | June 30, 2026 |
| 11 | FMR Inc | 1.18% | 20.8M | $5.93B | −988,917 (−4.5%) | June 30, 2026 |
| 12 | Northern Trust Corp | 1.16% | 20.6M | $5.87B | −652,935 (−3.1%) | June 30, 2026 |
| 13 | Franklin Templeton Inc | 1.13% | 19.9M | $5.69B | +5.4M (+36.9%) | June 30, 2026 |
| 14 | Capital World Investors | 1.09% | 19.2M | $5.47B | +3.3M (+21.1%) | June 30, 2026 |
| 15 | The Goldman Sachs Group Inc | 0.92% | 16.3M | $4.65B | +1.1M (+7.6%) | June 30, 2026 |
| 16 | Capital Research & Mgmt Co - Division 3 | 0.89% | 15.6M | $4.46B | +1.2M (+8.5%) | June 30, 2026 |
| 17 | T. Rowe Price Associates, Inc. | 0.83% | 14.7M | $4.21B | +1.7M (+13.4%) | June 30, 2026 |
| 18 | UBS Asset Mgmt Americas Inc | 0.81% | 14.3M | $4.07B | +106,091 (+0.7%) | June 30, 2026 |
| 19 | Charles Schwab Investment Management Inc | 0.73% | 12.9M | $3.69B | −53,168 (−0.4%) | June 30, 2026 |
| 20 | Bank of New York Mellon Corp | 0.73% | 12.9M | $3.67B | −424,793 (−3.2%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 16.0M shares and 10 cut 17.2M.
ABBV top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.18% | 56.2M | $16.03B | −108,600 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.66% | 46.9M | $13.40B | +557,193 (+1.2%) | August 31, 2026 |
| 3 | iShares Core S&P 500 ETF | 1.33% | 23.5M | $6.72B | −37,888 (−0.2%) | September 30, 2026 |
| 4 | Fidelity 500 Index | 1.30% | 22.9M | $6.55B | +88,085 (+0.4%) | August 31, 2026 |
| 5 | State Street® SPDR® S&P 500® ETF | 1.23% | 21.7M | $6.19B | — | September 30, 2026 |
| 6 | Vanguard MStar Value Index Investor | 0.96% | 16.9M | $4.82B | +57,063 (+0.3%) | August 31, 2026 |
| 7 | State Street®HlthCrSelSectSPDR®ETF | 0.71% | 12.5M | $3.58B | +38,976 (+0.3%) | September 30, 2026 |
| 8 | American Funds American Mutual A | 0.63% | 11.1M | $3.18B | +172,682 (+1.6%) | June 30, 2026 |
| 9 | Vanguard Dividend Appreciation ETF | 0.57% | 10.0M | $2.85B | +4,834 (+0.0%) | August 31, 2026 |
| 10 | American Funds Capital Inc Bldr A | 0.55% | 9.8M | $2.80B | +1.3M (+15.5%) | June 30, 2026 |
| 11 | American Funds Washington Mutual A | 0.54% | 9.6M | $2.75B | — | June 30, 2026 |
| 12 | Vanguard Institutional Index I | 0.53% | 9.4M | $2.70B | −91,398 (−1.0%) | August 31, 2026 |
| 13 | American Funds Income Fd of Amer A | 0.49% | 8.6M | $2.45B | +3.2M (+58.9%) | June 30, 2026 |
| 14 | Vanguard High Dividend Yield ETF | 0.41% | 7.2M | $2.05B | +52,215 (+0.7%) | August 31, 2026 |
| 15 | American Funds Invmt Co of Amer A | 0.37% | 6.5M | $1.86B | −1.8M (−21.5%) | June 30, 2026 |
| 16 | Fidelity SAI US Quality Index | 0.31% | 5.6M | $1.59B | +23,684 (+0.4%) | August 31, 2026 |
| 17 | Putnam Large Cap Value A | 0.31% | 5.5M | $1.56B | — | August 31, 2026 |
| 18 | Vanguard Health Care ETF | 0.31% | 5.4M | $1.54B | +17,844 (+0.3%) | August 31, 2026 |
| 19 | iShares Core Dividend Growth ETF | 0.26% | 4.7M | $1.33B | +838 (+0.0%) | September 30, 2026 |
| 20 | State Street® SPDR® Port S&P 500® ETF | 0.26% | 4.6M | $1.33B | −3,120 (−0.1%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ABBV insider transactions
latest 17| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Ro Khanna | Sell | $213.12 | — | — |
| 2026-03-04 | David Ryan Purdue | Sell | $233.56 | 5,230 | $1.2M |
| 2026-02-25 | Perry C Siatis | Sell | $230.00 | 22,381 | $5.1M |
| 2026-02-05 | Ro Khanna | Buy | $218.44 | — | — |
| 2026-01-29 | Ro Khanna | Sell | $220.42 | — | — |
| 2026-01-23 | Ro Khanna | Buy | $219.21 | — | — |
| 2025-12-18 | Julie Johnson | Sell | $222.87 | — | — |
| 2025-12-08 | Julia Letlow | Sell | $222.92 | — | — |
| 2025-11-13 | Julie Johnson | Sell | $232.25 | — | — |
| 2025-10-31 | Lisa C. McClain | Sell | $218.14 | — | — |
| 2025-10-30 | Lisa C. McClain | Sell | $228.35 | — | — |
| 2025-10-30 | Lisa C. McClain | Buy | $228.35 | — | — |
| 2025-08-22 | John Boozman | Sell | $210.28 | — | — |
| 2025-08-14 | Julie Johnson | Sell | $204.78 | — | — |
| 2025-08-12 | Azita Saleki-Gerhardt | Sell | $198.42 | 42,370 | $8.4M |
| 2025-08-11 | John Boozman | Sell | $198.46 | — | — |
| 2025-08-05 | Nicholas Donoghoe | Sell | $198.51 | 13,295 | $2.6M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ABBV shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ABBV
Institutional investors own 77.3% of AbbVie's shares and insiders 0.11%. The largest holder is BlackRock Inc with 8.46% of the shares (149.5M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 10 reduced their stake in the latest filings. Short interest is 1.02% of the float, or 3.93 days of average trading volume. The share count rose 11.1% since 2014.
Related: ABBV analyst forecast, ABBV key metrics, ABBV dividend history. See the ABBV stock overview for the latest quote and news.
ABBV ownership FAQ
Who owns the most AbbVie stock?
The largest shareholders of AbbVie are BlackRock Inc (8.46%), Vanguard Capital Management, LLC (6.53%), State Street Corp (4.67%), Vanguard Portfolio Management, LLC (2.74%), JPMorgan Chase & Co (2.71%).
What percentage of AbbVie is owned by institutions?
Institutions hold 77.3% of AbbVie's shares outstanding; insiders hold 0.11%.
Which funds own AbbVie?
The largest fund holders of AbbVie are Vanguard MStar Total Stk Mkt Idx Invest (3.18%), Vanguard 500 Index Investor (2.66%), iShares Core S&P 500 ETF (1.33%), Fidelity 500 Index (1.30%), State Street® SPDR® S&P 500® ETF (1.23%).
What is AbbVie's short interest?
16.3M shares of AbbVie were sold short, 1.02% of the float; at the average daily volume it would take 3.93 days to cover.
Are insiders buying or selling AbbVie?
Of the latest 17 reported insider transactions in AbbVie (since August 5, 2025), 3 were purchases and 14 were sales.
How many shares of AbbVie are outstanding?
AbbVie has 1.77B shares outstanding, of which 1.76B are in the public float.